Literature DB >> 12759857

Fourier analysis of corneal astigmatic changes following photorefractive keratectomy.

Kenichiro Bessho1, Naoyuki Maeda, Hitoshi Watanabe, Yoshikazu Shimomura, Yasuo Tano.   

Abstract

The purpose of this study was to evaluate the corneal irregular astigmatism following photorefractive keratectomy (PRK) for myopia. The corneal topography of 30 eyes of 26 patients was measured with the TMS-1 videokeratoscope before and 1 month after PRK. Axial dioptric data were decomposed into four components; A0 (Sphericity), C1 x 2 (Asymmetry), C2 x 2 (Regular astigmatism), and C3 (higher-order irregularity) for the central 3 and 6 mm zone by Fourier series harmonic analysis. Post-operative topographies were divided into those with an irregular and those with a homogeneous pattern, and the Fourier components were compared. In the 6 mm zone, A0 was significantly decreased (P < 0.001), and C1 x 2, C2 x 2, and C3 were significantly increased (P = 0.001, 0.005, 0.002, respectively). In the 3 mm zone, A0 decreased (P < 0.001) and C1 x 2 increased (P < 0.001) significantly. C1 x 2 was correlated with the post-operative corrected visual acuity (P < 0.001, r = 0.647). The irregular pattern group had a larger C1 x 2 component (P < 0.001). The treatment displacement was not correlated with any component. In conclusion, irregular topography due to intraoperative drift or asymmetrical wound healing may play a more important role in the post-operative corneal optical property than mild treatment displacement.

Entities:  

Mesh:

Year:  2003        PMID: 12759857     DOI: 10.1076/soph.18.1.23.14073

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  1 in total

1.  Outcomes of photorefractive keratectomy instead of phototherapeutic keratectomy for patients with granular corneal dystrophy type 2.

Authors:  Fumika Oya; Takeshi Soma; Yoshinori Oie; Takeshi Nakao; Shizuka Koh; Motokazu Tsujikawa; Naoyuki Maeda; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-11       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.